Effectiveness of Maternal Immunization With Boostrix at Preventing

See also
Status	Clinical Trial	Phase
Completed	`NCT03035370` - Viaskin Pertussis Vaccine Trial	Phase 1
Completed	`NCT02453048` - Study of BPZE1 (High Dose) Nasal Live Attenuated B. Pertussis Vaccine	Phase 1
Completed	`NCT01444781` - Study of the Booster Effect of DTaP-IPV-Hep B-PRP~T Combined Vaccine or Infanrix Hexa™ and Prevenar™ in Healthy Infants	Phase 3
Active, not recruiting	`NCT05091619` - A Phase 3 Study of BIBP Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed	Phase 3
Completed	`NCT02587520` - Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed in Healthy Subjects	Phase 1/Phase 2
Completed	`NCT01983540` - Antibody Persistence at Age 3.5 and 4.5 Years After Primary and Booster DTaP-IPV-Hep B-PRP~T or Infanrix Hexa Vaccination	Phase 3
Completed	`NCT01545115` - Study of the Environmental Factors Modulating Children Immune Response in Northern Senegal	N/A
Recruiting	`NCT04238975` - A Study to Evaluate the Safety and Efficacy(Immunogenicity) of GC3111 in Healthy Adults	Phase 2
Completed	`NCT01439165` - Safety and Immunogenicity in Adults of Revaccination With Adacel® Vaccine 10 Years After a Previous Dose	Phase 4
Recruiting	`NCT03751514` - Bordetella Pertussis Colonisation Challenge Study	N/A
Active, not recruiting	`NCT01279668` - Montelukast for Persistent Cough in Young People and Adults	Phase 4
Completed	`NCT00337428` - Concomitant Use of Gardasil (V501, Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diptheria, Tetanus, Pertussis and Poliomyelitis Vaccine in Adolescents (V501-024)(COMPLETED)	Phase 3
Completed	`NCT00662870` - Study of the Safety, Immunogenicity and Lot Comparability of DAPTACEL When Administered With Other Recommended Vaccine	Phase 3
Completed	`NCT01529645` - Safety and Dose Ranging Study of Acellular Pertussis and Acellular Pertussis -Tetanus-Diphtheria Booster Vaccines in Healthy Adults Ages 18 to 40 Years	Phase 1
Recruiting	`NCT04036526` - A Phase 1/2 Clinical Trial of a GamLPV, a Live Intranasal Bordetella Pertussis Vaccine	Phase 1/Phase 2
Active, not recruiting	`NCT02813486` - Safety and Immunogenicity Study of Tetanus, Diphtheria and Acellular Pertussis (Tdap) Vaccine	Phase 1/Phase 2
Completed	`NCT01629589` - Immunogenicity of Adacel® and BOOSTRIX® Vaccines in Adolescents	Phase 4
Completed	`NCT03942406` - Study of BPZE1 Intranasal Pertussis Vaccine (Administered Via VaxINator(TM)), Prime + Boost, in Healthy Adults	Phase 2
Completed	`NCT03137927` - A Phase I Clinical Study of a GamLPV, a Live Intranasal Bordetella Pertussis Vaccine	Phase 1
Completed	`NCT02301702` - Maternal Tdap Immunization in Guatemala	Phase 2

NCT number	NCT03973905
Study type	Observational
Source	GlaxoSmithKline
Contact
Status	Completed
Phase
Start date	February 15, 2019
Completion date	May 15, 2019

Effectiveness of Maternal Immunization With Boostrix at Preventing Pertussis Among Infants <2 Months Old in the United States

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms